Management of Mitral Regurgitation
Indications for Surgery
- The American College of Cardiology recommends surgery for all symptomatic patients with severe primary mitral regurgitation and left ventricular ejection fraction (LVEF) >30%, regardless of the degree of left ventricular (LV) dysfunction, which represents a Class I indication across all major guidelines 1, 2.
- The American Heart Association suggests that even patients with LVEF between 30-60% should undergo surgery when symptomatic, as this improves survival and prevents irreversible cardiac damage 1.
- For symptomatic patients with LVEF <30%, surgery may still be considered if they remain refractory to medical therapy, but only when there is a high likelihood of durable repair and low comorbidity 3.
- Mitral valve repair is strongly preferred over replacement when feasible, particularly for degenerative disease involving the posterior leaflet, as recommended by the American College of Cardiology 1, 2.
Asymptomatic Primary Mitral Regurgitation with LV Dysfunction
- The European Society of Cardiology recommends surgery for asymptomatic patients who develop LV dysfunction defined as LVEF ≤60% and/or left ventricular end-systolic diameter (LVESD) ≥40 mm, which represents a critical point where compensatory mechanisms begin to fail and irreversible myocardial damage occurs 1, 2, 4.
- The LVESD threshold of 40 mm should be adjusted downward (to 22 mm/m² body surface area) in patients of small stature, according to the European Heart Journal 4.
- Early surgery at these thresholds (within 2 months of meeting criteria) is associated with better outcomes than delayed intervention, as reported by the European Heart Journal 4.
Asymptomatic Primary Mitral Regurgitation with Preserved LV Function
- New-onset atrial fibrillation warrants surgical consideration in asymptomatic patients with preserved LV function, as recommended by the European Society of Cardiology 4, 3.
- Pulmonary hypertension (systolic pulmonary artery pressure >50 mmHg at rest) is an indication for surgery in asymptomatic patients with preserved LV function, according to the European Heart Journal 4, 3.
- Flail leaflet with LVESD ≥40 mm should prompt surgical evaluation in asymptomatic patients with preserved LV function, as suggested by the European Heart Journal 4.
Secondary Mitral Regurgitation
- The American College of Cardiology recommends that surgery or intervention for secondary mitral regurgitation should only be considered in symptomatic patients who remain symptomatic despite optimal guideline-directed medical therapy, including cardiac resynchronization therapy if indicated 2, 3.
- For patients undergoing coronary artery bypass grafting with LVEF >30%, concomitant mitral valve surgery is recommended when severe secondary mitral regurgitation is present, as suggested by the American College of Cardiology 3.
- Transcatheter edge-to-edge repair should be considered in symptomatic patients with LVEF >30%, appropriate anatomy, and no indication for revascularization after optimal medical therapy, according to the American College of Cardiology 3.
Transcatheter Options
- The American College of Cardiology recommends that transcatheter edge-to-edge repair may be considered as an alternative to surgery only in symptomatic patients with severe primary mitral regurgitation who are at high or prohibitive surgical risk and have favorable anatomy 2, 3.
- For primary mitral regurgitation, transcatheter edge-to-edge repair is reasonable when LVEF is 20-50%, LVESD ≤70 mm, and pulmonary artery systolic pressure ≤70 mmHg, as suggested by the American College of Cardiology 3.
- For secondary mitral regurgitation, transcatheter edge-to-edge repair should be considered in symptomatic patients meeting COAPT criteria who remain symptomatic after optimal medical therapy, according to the American College of Cardiology 2, 3.
Monitoring Strategy
- Asymptomatic severe mitral regurgitation requires follow-up every 6-12 months with echocardiography, as recommended by the European Society of Cardiology 3.
- Asymptomatic moderate mitral regurgitation with preserved LV function requires yearly clinical follow-up with echocardiography every 1-2 years, according to the European Society of Cardiology 3.
- More frequent reassessment is needed if progressive LV dilation is occurring, as suggested by the European Society of Cardiology 3.
- Consider exercise echocardiography, Holter monitoring, and cardiac MRI for risk stratification in borderline cases, according to the European Society of Cardiology 3.
Indications and Timing for Mitral Valve Intervention in Primary Mitral Regurgitation
Symptomatic Patients with Left‑Ventricular Dysfunction
- Class I recommendation (ACC/AHA): Adults with symptomatic severe primary MR and left‑ventricular ejection fraction (LVEF) ≤ 60 % or left‑ventricular end‑systolic dimension (LVESD) ≥ 40 mm should undergo mitral valve surgery immediately, with repair preferred over replacement. 5
- Class I recommendation (ACC/AHA): Surgery is indicated for all symptomatic patients with severe primary MR when LVEF is between 30 %–60 % and/or LVESD ≥ 40 mm. [5][6]
- Evidence of harm: Delaying surgery after the onset of LV systolic dysfunction leads to irreversible myocardial injury and poorer long‑term survival. 5
Symptomatic Patients with Preserved Left‑Ventricular Function
- Class I recommendation (ACC/AHA): In patients with mild symptoms (NYHA II) and severe MR, surgery is advised when LVEF > 60 % and LVESD < 40 mm, provided a durable repair is feasible. [7][6]
- Class I recommendation (ACC/AHA): The mere presence of symptoms together with severe MR constitutes an indication for intervention, irrespective of LV size or function. 5
Asymptomatic Patients
- Class I recommendation (ACC/AHA): Surgery is indicated once LVEF declines to ≤ 60 % or LVESD reaches ≥ 40 mm, even in the absence of symptoms. 5
- Pathophysiologic rationale: These thresholds mark the failure of compensatory mechanisms and the onset of irreversible ventricular damage. 5
- Class IIa recommendation (ACC/AHA): Earlier surgery should be considered when serial imaging shows progressive LV dilation or a trend toward the LVEF/LVESD thresholds. 5
- Class IIa recommendation (ACC/AHA): New‑onset atrial fibrillation or resting pulmonary artery systolic pressure > 50 mm Hg in otherwise asymptomatic patients with preserved LV function also justify surgical referral. 5
Preference for Mitral Valve Repair Over Replacement
- Class I recommendation (ACC/AHA): Mitral valve repair is strongly preferred to replacement when a durable repair can be achieved. 5
- High success in posterior leaflet disease: Repair success rates exceed 95 % for isolated posterior leaflet pathology. 5
- Repair of anterior or bileaflet disease: Still preferred when a durable result is attainable. 5
- Residual orifice size: A residual mitral valve orifice area ≥ 2 cm² is advised to avoid iatrogenic mitral stenosis (guideline does not mandate an exact cut‑off). 8
Indications for Mitral Valve Replacement and Contraindications to Repair
- Class I recommendation (ACC/AHA): Replacement is reserved for cases where repair is technically infeasible or has failed. [5][6]
- Chordal‑sparing technique: When replacement is performed, preservation of the chordae tendineae is required to maintain LV geometry and function. [7][6]
- Advanced LV dysfunction: Patients with LVEF < 30 % may need replacement if repair is impossible, but only if chordal preservation can be achieved. 6
- Contraindication (ESC): Severe rheumatic disease with marked leaflet thickening and commissural fusion precludes repair. 8
Referral and Center Expertise
- Avoid delayed referral: Do not wait for LVEF < 60 % or LVESD > 40 mm before referring symptomatic patients; these values already indicate established LV dysfunction. [5][6]
- Referral to high‑volume centers: All patients meeting surgical criteria should be referred to experienced mitral‑valve centers where repair rates exceed 95 % and operative mortality is < 1 %. 5